Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Plexus Corp (NASDAQ: PLXS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Plexus files periodic and current reports as a Wisconsin corporation with Commission File Number 001-14423.
Among the key documents available are current reports on Form 8-K, which Plexus uses to furnish press releases announcing quarterly and annual financial results. These filings typically include information on revenue, operating margin, earnings per share, non-GAAP performance measures, return on invested capital, free cash flow and other financial metrics, as well as commentary on business conditions and program wins.
Through this page, users can track how Plexus reports its results for fiscal quarters and years, including references to its geographic segments in the Americas, Asia-Pacific and Europe, Middle East and Africa regions, and its focus on Aerospace/Defense, Healthcare/Life Sciences and Industrial market sectors. Filings also confirm corporate details such as state of incorporation and principal corporate location.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, helping readers quickly understand the implications of each report. Real-time updates from the SEC’s EDGAR system, along with structured access to forms such as 8-K and other periodic reports, make it easier to review Plexus’ regulatory history and monitor ongoing disclosures related to PLXS.
Plexus Corp President & CEO Todd P. Kelsey reported an open-market sale of 1,500 shares of common stock. The shares were sold on April 15, 2026 at a weighted average price of $224.0867 per share. Following this transaction, he directly holds 80,291 shares of Plexus common stock.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 20, 2025, and occurred through multiple trades within a price range of $223.98 to $224.30 per share.
Plexus Corp (common stock) is reported in an amended Schedule 13G/A filing by Dimensional Fund Advisors LP. The filing states Dimensional's affiliated Funds beneficially own 1,119,371 shares, representing 4.2% of the class, with 1,092,142 shares of sole voting power. Dimensional disclaims beneficial ownership and notes the shares are owned by the Funds. The filing is signed by the Global Chief Compliance Officer on 04/09/2026.
The Vanguard Group amended its Schedule 13G/A to report 03/13/2026 as the relevant date and zero shares of Plexus Corp common stock beneficially owned. The filing (Amendment No. 18) states 0 shares and 0% ownership and includes a disclosure that Vanguard completed an internal realignment on January 12, 2026, after which certain subsidiaries will report holdings separately.
PLEXUS CORP President & CEO Todd P. Kelsey reported an open-market sale of 1,500 shares of common stock at $194.24 per share. After this transaction, he directly holds 81,791 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 20, 2025.
Plexus Corp director Karen Marie Rapp reported an open-market sale of 500 shares of common stock at $195.59 per share on February 27, 2026. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 28, 2024.
After this transaction, Rapp directly holds 8,535 Plexus shares, reflecting a modest reduction in her direct ownership.
Plexus Corp executive Michael J. Running, Regional President - AMER, sold 700 shares of Plexus common stock in an open-market transaction. The shares were sold at an average price of $205.4698 per share. After this sale, he directly holds 1,175 shares of Plexus common stock.
Plexus Corp director Randy J. Martinez reported an open-market sale of 1,000 shares of common stock on February 25, 2026 at an average price of $203.1401 per share. After this transaction, he directly owns 5,201 Plexus shares.
PLXS insider sale notice: Michael J. Running reported the sale of 926 common shares on 02/02/2026 for $189,756.01. The filing also lists performance-share line items of 580 (dated 02/17/2026) and 120 (dated 11/16/2023) under "Securities To Be Sold."
Plexus Corp reported that Regional President – APAC Victor (Pang Hau) Tan received equity compensation tied to company performance. He was granted 602 Performance Stock Units at a price of $0.00 per unit.
In addition, 2,022 Performance Stock Units were exercised and converted into 2,022 shares of common stock at $0.00 per share, reflecting vesting of fiscal 2023 awards. A footnote explains that, based on company performance over a three-year period, 142.4% of the targeted PSUs tied to relative total shareholder return vested, compared with a maximum opportunity of 150%. After these transactions, Tan directly owned 13,457 shares of Plexus common stock.